323 related articles for article (PubMed ID: 35146629)
1. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer.
ZeinElAbdeen YA; AbdAlSeed A; Youness RA
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):79-99. PubMed ID: 35146629
[TBL] [Abstract][Full Text] [Related]
2. Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.
Biello F; Platini F; D'Avanzo F; Cattrini C; Mennitto A; Genestroni S; Martini V; Marzullo P; Aimaretti G; Gennari A
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477996
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Long Noncoding RNA Linc01287 Promotes IGF1R Expression by Sponging miR-98 in Breast Cancer.
Guo C; Zhang M; Qian J; Li P; Guo L
Crit Rev Eukaryot Gene Expr; 2022; 32(3):31-44. PubMed ID: 35695608
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.
Ochnik AM; Baxter RC
Endocr Relat Cancer; 2016 Nov; 23(11):R513-R536. PubMed ID: 27733416
[TBL] [Abstract][Full Text] [Related]
6. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer.
Dastmalchi N; Safaralizadeh R; Latifi-Navid S; Banan Khojasteh SM; Mahmud Hussen B; Teimourian S
Expert Rev Mol Diagn; 2021 Oct; 21(10):1025-1036. PubMed ID: 34334086
[No Abstract] [Full Text] [Related]
7. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
8. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
9. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.
Hamelers IH; Steenbergh PH
Endocr Relat Cancer; 2003 Jun; 10(2):331-45. PubMed ID: 12790794
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract][Full Text] [Related]
11. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?
Gray SG; Stenfeldt Mathiasen I; De Meyts P
Horm Metab Res; 2003; 35(11-12):857-71. PubMed ID: 14710369
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma.
El Tayebi HM; Abdelaziz AI
World J Gastroenterol; 2016 Mar; 22(9):2668-77. PubMed ID: 26973407
[TBL] [Abstract][Full Text] [Related]
14. Regulation of breast cancer metastasis by IGF signaling.
Sachdev D
J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):431-41. PubMed ID: 19030970
[TBL] [Abstract][Full Text] [Related]
15. Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer.
Dey P; Joshi M; Mujawar A; Malhotra R; De A
Cell Oncol (Dordr); 2022 Oct; 45(5):873-891. PubMed ID: 35834098
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors in human breast cancer.
Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells.
Richardson AE; Hamilton N; Davis W; Brito C; De León D
Growth Factors; 2011 Apr; 29(2-3):82-93. PubMed ID: 21410323
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer.
Byron SA; Yee D
Semin Oncol; 2003 Oct; 30(5 Suppl 16):125-32. PubMed ID: 14613033
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
20. Role of long non-coding RNAs and TGF-β signaling in the regulation of breast cancer pathogenesis and therapeutic targets.
Hussen BM; Hidayat HJ; Abdullah SR; Mohamadtahr S; Rasul MF; Samsami M; Taheri M
Cytokine; 2023 Oct; 170():156351. PubMed ID: 37657235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
